bluebird bio Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Everybody, thanks for joining us for the next session. I'm Matthew Harrison, I'm one of the biotech analysts here at Morgan Stanley. Pleased to have Bluebird with me for the next session.
Quickly before we get started, I need to read a disclaimer. Please note that this webcast is for Morgan Stanley clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately.
For important disclosures, please see the Morgan Stanley research disclosures website at morganstanley.com/research disclosures. And if you have any questions, please reach out to your Morgan Stanley representative.
And with that, very pleased to have Nick Leschly, the CEO of Bluebird, as well as Philip Gregory. And Nick, I'm going to turn it over to you to start off, to give us some opening comments, and then we'll jump into Q&A.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |